New drug to protect babies and toddlers from RSV gets F...
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year
Source: accesswdun.com
Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year
Lockdown-related changes in care delivery led to increased antibiotic prescribing, the study finds.
U.S. officials approved the first long-acting drug to protect babies and toddlers against RSV.
This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old in the United States every year.